Epoch Investment Partners Inc. Purchases 831,199 Shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO)

Epoch Investment Partners Inc. raised its position in Halozyme Therapeutics, Inc. (NASDAQ:HALO – Free Report) by 250.5% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 1,163,033 shares of the biopharmaceutical company’s stock after buying an additional 831,199 shares during the quarter. Epoch Investment Partners Inc.’s holdings in Halozyme Therapeutics were worth $42,986,000 […]

Related Keywords

Japan ,Switzerland ,Belgium ,United States ,Piper Sandler ,Michaelj Labarre ,Headlands Technologies ,Parkside Financial Bank ,Halozyme Therapeutics Inc ,Principal Securities Inc ,Holdings Channel ,Nasdaq ,Epoch Investment Partners Inc ,Quadrant Capital Group ,First Horizon Advisors Inc ,Wells Fargo Company ,Epoch Investment Partners ,Halozyme Therapeutics ,Free Report ,Investment Partners ,Horizon Advisors ,Financial Bank ,Capital Group ,Therapeutics Trading Down ,Get Free Report ,Visit Holdingschannel ,Halozyme Therapeutics Daily ,